Risk of serious conditions reduced regardless of amount of weight lost, say researchers who compare breakthrough to discovery ...
Those taking the drugs for at least three years cut their risk of heart attack, stroke or cardiac death by 20 per cent ...
Find your bookmarks in your Independent Premium section, under my profile Weight loss jabs like Ozempic can cut the risk of heart attacks or strokes by a fifth, a “game-changing” new study has ...
Obesity jabs could cut the risk of heart attacks and strokes in people even if they fail to lose much weight, according to an analysis of a study funded by a drug manufacturer. Researchers looked ...
Novo Nordisk’s weight loss injection semaglutide — the ingredient inside its wildly popular drugs Ozempic and Wegovy — could ...
A groundbreaking study has revealed that an anti-obesity jab containing semaglutide, a drug used to treat obesity, significantly reduces the risk of heart attacks and strokes, regardless of the ...
New analyses of a large trial presented at the European Congress on Obesity showed the clear benefits of the popular ...
Its famous as a weight loss jab but effects are much more wide-ranging (Picture: Getty/Metro.co.uk) Ozempic could dramatically reduce the risk of heart attacks and stroke, a new study indicates.
The popular weight-loss drug Wegovy, which has helped millions of Americans shed pounds, can now be used to reduce the risk ...
An anti-obesity drug could have additional health benefits including reducing the risk of heart attacks and strokes a new study has revealed. A five-year study was carried out by a team led ...